Title(s):
Professor of Ophthalmology
George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience
Appointment Phone:
410-955-3518
Primary Location:
Johns Hopkins Wilmer Eye Institute
Expertise:
Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Age-Related, Macular Holes, Macular Puckers, Ophthalmology, Proliferative Vitreoretinopathy, Retinal Detachment, Retinal Vessel Occlusion
Education and Experience
Training
- Johns Hopkins University School of Medicine (Baltimore MD)/ (1978)
Residencies
- University of Virginia Health System (Charlottesville VA)/ Ophthalmology (1982)
Certifications
- Ophthalmology, American Board of Ophthalmology (1983)
Locations
Johns Hopkins Wilmer Eye Institute
600 N. Wolfe Street
Baltimore, MD 21287
Appointment Phone: 410-955-3518
Fax: 410-617-7083
Location Map
Department / Division
-
Ophthalmology - Retina
Centers/Institutes
Centers / Institutes
- Wilmer Eye Institute
Bio
Biography
Dr. Campochiaro was trained at the University of Notre Dame, Johns Hopkins School of Medicine, the University of Virginia, and Wilmer, joining the Wilmer Faculty in 1991. He is currently the George S. and Dolores Dor Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Institute. His major research interests are in gaining a greater understanding of the roles of peptide growth and trophic factors in the retina and retinal pigmented-epithelium with an ultimate goal of developing new treatments for proliferative retinopathies, choroidal neovascularization and retinal degenerations.
Physician Title
George S. and Dolores Dore Eccles Professor of Ophthalmology and Neuroscience
Expertise
- Diabetic Macular Edema
- Diabetic Retinopathy
- Macular Degeneration, Age-Related
- Macular Holes
- Macular Puckers
- Ophthalmology
- Proliferative Vitreoretinopathy
- Retinal Detachment
- Retinal Vessel Occlusion
Research
Research Interests
- Ocular Gene Therapy
- Clinical trials of ocular neovascularization and macular edema
- Development of new treatments for retinal degenerations
- Mechanisms involved in retinal degenerations
- Development of new treatments for ocular neovascularization
- Mechanisms involved in ocular neovascularization
More Info
Languages
- English
Clinical Trials
- Diabetic macular edema
- Ranibizumab
- Central retinal vein occlusion
- Branch retinal vein occlusion
- Choroidal neovascularization
- Gene therapy
Additional Resources
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts